Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-15

Clinical Trial Update: Quality of Life Study Using Gabapentin Versus Venlafaxine in Treating Hot Flashes in Patients With Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing gabapentin to venlafaxine for hot flashes in prostate cancer patients; study terminated with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)
  • Venlafaxine (Venlafaxine)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-09-15